Coldsnap
HealthPillar

Nobody has studied quitting pouches yet. Here is the nearest evidence.

There is no clinical trial on how to quit nicotine pouches. That gap is the honest starting point. Here is what the closest research, on snus and smokeless tobacco, can and cannot tell us.

By Evan, founder of Coldsnap
Published August 21, 2026

Most quit guides project confidence. This one starts with a gap, because the gap is the most useful true thing we can tell you.

The honest starting point

There is no clinical trial on how to quit nicotine pouches. Not on cold turkey versus taper for pouches, not on stepping down strength, not on the withdrawal course in pouch users specifically. Pouches are new enough that the research simply has not been done. Anyone who tells you the proven pouch-quit protocol is inventing the word proven.

So what do you stand on instead? The nearest neighbours, clearly labelled as neighbours.

What the nearest evidence says

Snus and smokeless tobacco cessation. This is the closest studied behaviour. A 2025 Cochrane review found that behavioural support helps, and that the medication varenicline improves quit rates for smokeless-tobacco users. Notably, nicotine patch and gum did not show a clear benefit for this group, which is a real difference from the cigarette playbook. Useful direction, but it is snus and dip, not pouches.

How strong the hold is. Dependence on snus looks comparable to cigarettes, not obviously milder. That squares with what a lot of people report about pouches: the all-day, low-key use is easy to underestimate and stubborn to drop.

Reduction versus stopping. In smoking research, cutting down first works about as well as quitting abruptly. Comparable, not better. Transferred to pouches, that is an analogy, so we hold it loosely.

One thing pouches are not

A 2025 systematic review found no significant smoking-cessation benefit from nicotine pouches. Whatever else they are, they are not a proven way to quit cigarettes, and we never present them as one.

What this means for you

The lack of a pouch-specific trial does not leave you with nothing. It leaves you with general nicotine science, the smokeless-tobacco evidence as the closest analogue, and the cessation frameworks that public-health bodies already publish: set a plan, have a way to ride out cravings, and reduce or stop at a pace you can hold.

That is what this app is built around. It is designed to support a quit using those evidence-based strategies. It is not a treatment, and it has not been trial-tested to make anyone quit, because nothing for pouches has. When the research catches up, we will update what we say. Until then, honesty is the feature.

This is general information, not medical advice.

Not medical advice. This is general information and a self-help tool, not treatment. Nicotine-replacement therapy is FDA-approved and worth discussing with a clinician.

Sources

  1. 1.Cochrane review, interventions for smokeless tobacco cessation, 2025 (CD015314) · varenicline and behavioural support help smokeless users; via WHO guideline
  2. 2.Fagerström, 2018, dependence on snus versus cigarettes (PMC6121467) · snus dependence comparable to cigarettes
  3. 3.Heshmati et al., 2025, Addiction, systematic review of pouches for smoking cessation · no significant smoking-cessation benefit from pouches (7 RCTs)
The app

A calmer way down, in your pocket

Log in a tap, taper at your pace, and keep your progress even after a slip. iPhone first, and private by design.

Get early access